Meet The Team

James Lanthier

Chief Executive Officer

A seasoned technology executive with strong expertise in corporate finance, public markets and M&A. Most recently, Mr. Lanthier was a co-founder and CEO of Future Fertility, an innovative early stage developer of AI applications for human infertility. As a C-Suite executive, Mr. Lanthier has assisted in the growth and successful exit of numerous technology-enabled businesses through the public markets, including Mood Media, the world’s largest in-store media provider, and Fun Technologies, a pioneer in online casual games.

Arvin Ramos

Chief Financial Officer

Mr. Ramos holds a degree in commerce and a member of the Chartered Professional Accountants of Ontario.  Mr. Ramos has over 15 years of business experience, having supported a broad range of industries, including mining, technology and banking. Mr. Ramos serves as CFO of several junior mining companies.

Joseph Araujo

Chief Scientific Officer

A behavioural pharmacologist with extensive experience in facilitating the discovery and development of novel CNS drugs. He has co-founded, held executive level positions and consulted for Life Science  companies including CanCog Technologies, Vivocore, Karyopharm Therapeutics, NPM Pharma, Ketogen, and Epione Animal Health. He did his graduate training in pharmacology at the  University of Toronto and has done extensive research examining psychoactive drugs.

Malik Slassi

Senior VP of Innovation
Dr. Slassi was the Founder, President and Chief Scientific Officer of Fluorinov Pharma Inc. acquired by Trillium Therapeutics (NASDQ: TRIL) in January 2016. He is a medicinal chemist with a remarkable track record of success in drug discovery & development in the biopharmaceutical industry, spanning a period of over 30 years.  He has significant experience in the successful identification and development of drug candidates across multiple therapeutic areas including Neurology, Psychiatry and Immunology. Dr. Slassi has extensive experience in the areas of intellectual property management, corporate and scientific operations. He is an accomplished inventor with over 130 issued and published patents and patent applications, and author of more than 65 scientific and review articles. Dr. Slassi holds a Ph.D. in chemistry from the University of Claude Bernard, Lyon, France and completed his postdoctoral training at the Chemistry Department of the University of Montreal, Canada.

Jason Atkinson

Corporate Development

A finance professional with experience in private equity, venture capital, investment banking and corporate finance. He has played a key role in raising capital and providing advisory services to private and publicly listed entities across multiple industries. He holds an MBA from the Degroote School of Business and is a CFA Charterholder.